Women's experiences in injectable opioid agonist treatment programs in Vancouver, Canada
- PMID: 37192557
- PMCID: PMC10330495
- DOI: 10.1016/j.drugpo.2023.104054
Women's experiences in injectable opioid agonist treatment programs in Vancouver, Canada
Abstract
Background: Injectable opioid agonist treatment (iOAT) has recently been expanded in some geographical contexts in Canada as part of a response to the escalating overdose crisis. Complex gendered dynamics, including power differentials, violence, and social norms, shape the overdose crisis and drug treatment programs which can adversely impact women's experiences. This qualitative study examines how social (e.g., gender, income, housing) and structural factors (e.g., program policies) impact women's experiences of iOAT.
Methods: Qualitative interviews were completed with 16 women enrolled in four iOAT programs in Vancouver, Canada. Approximately 50 hours of ethnographic observations were conducted. Interview transcripts and ethnographic fieldnotes were analyzed using a critical feminist lens by applying the concepts of embodiment, relationality, and social control to understand women's engagement and self-reported treatment outcomes.
Results: Initial iOAT engagement was a relational process, including initiating treatment with a partner and engaging with iOAT to (re)build personal relationships. Relationships with iOAT providers, including flexibility and support with medication administration, were important to women, providing an affirming embodied experience and a greater sense of agency. However, program operations (e.g., mandated daily attendance, program crowding) incompatible with women's needs (e.g., employment) could undermine these positive experiences. Women's reported outcomes highlight a tension between achieving more agency and the constraints of intensive and stigmatized treatment.
Conclusion: This study highlights how iOAT is both a source of care and control for women from a relational and embodied perspective. Findings underscore the need for gender-attentive and flexible drug treatment services to meet the varied needs of women and the importance of providing relational care for women accessing iOAT.
Keywords: Drug treatment; Opioids; Qualitative; Women.
Copyright © 2023 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declarations of Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Barriers and facilitators to injectable opioid agonist treatment engagement within a structural vulnerability context: a qualitative study of patient experiences in Vancouver, Canada.Harm Reduct J. 2025 Jul 4;22(1):116. doi: 10.1186/s12954-025-01262-4. Harm Reduct J. 2025. PMID: 40615907 Free PMC article.
-
Navigating fragmented services: a gender-based violence (GBV) critical feminist analysis of women's experiences engaging with health and social supports in three Canadian cities.BMC Public Health. 2025 Mar 31;25(1):1213. doi: 10.1186/s12889-025-21919-w. BMC Public Health. 2025. PMID: 40165159 Free PMC article.
-
Women's experience of menopause: a systematic review of qualitative evidence.JBI Database System Rev Implement Rep. 2015 Sep 16;13(8):250-337. doi: 10.11124/jbisrir-2015-1948. JBI Database System Rev Implement Rep. 2015. PMID: 26455946
-
Gender differences in the context of interventions for improving health literacy in migrants: a qualitative evidence synthesis.Cochrane Database Syst Rev. 2024 Dec 12;12(12):CD013302. doi: 10.1002/14651858.CD013302.pub2. Cochrane Database Syst Rev. 2024. PMID: 39665382
-
Sexual Harassment and Prevention Training.2024 Mar 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2024 Mar 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 36508513 Free Books & Documents.
Cited by
-
Challenges for the implementation of injectable opioid agonist treatment: a scoping review.Harm Reduct J. 2024 Dec 4;21(1):217. doi: 10.1186/s12954-024-01102-x. Harm Reduct J. 2024. PMID: 39633369 Free PMC article.
-
A qualitative evaluation of a fentanyl patch safer supply program in Vancouver, Canada.Int J Drug Policy. 2024 Sep;131:104547. doi: 10.1016/j.drugpo.2024.104547. Epub 2024 Aug 17. Int J Drug Policy. 2024. PMID: 39159532 Free PMC article.
-
Using drugs alone in single room occupancy housing: Understanding environmental drivers of overdose risk.Int J Drug Policy. 2024 Jun;128:104444. doi: 10.1016/j.drugpo.2024.104444. Epub 2024 May 15. Int J Drug Policy. 2024. PMID: 38754243 Free PMC article.
-
"It's a delicate balance": clinicians' experiences of providing heroin-assisted treatment.Harm Reduct J. 2024 Dec 31;21(1):230. doi: 10.1186/s12954-024-01135-2. Harm Reduct J. 2024. PMID: 39741328 Free PMC article.
-
Reimagining subjectivities in place: Necropolitical logics of safer supply and housing in Vancouver's Downtown Eastside.Soc Sci Med. 2025 May;372:117930. doi: 10.1016/j.socscimed.2025.117930. Epub 2025 Mar 5. Soc Sci Med. 2025. PMID: 40088666
References
-
- BC Centre on Substance Use, BC Ministry of Health, & CRISM. (2021). Guidance for Injectable Opioid Agonist Treatment for Opioid Use Disorder
-
- Bourgois P (2000). Disciplining addictions: The bio-politics of methadone and heroin in the United States. Culture, Medicine and Psychiatry, 24(2), 165–195. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources